HSDT

Helius Medical Technolog... Stock Price

16.79
0.38 (2.32%)
Upgrade to Real-Time
Regular Market
16.79

Low
11.00

52 Week Range

High
34.00

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Helius Medical Technologies Inc HSDT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.38 2.32% 16.79 15:15:58
Open Price Low Price High Price Close Price Prev Close
16.73 16.29 16.79 16.41
Bid Price Ask Price Spread News
16.66 16.87 0.21 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
91 5,311 $ 16.64 $ 88,360 18,470 11.00 - 34.00
Last Trade Time Type Quantity Stock Price Currency
15:15:16 5 $ 16.84 USD

Helius Medical Technolog... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 711.66k 42.39k 20.27M $ 683.79k $ - -1.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Helius Medical Technolog... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HSDT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.5816.7914.5816.2725,0702.2115.16%
1 Month13.3616.7913.1814.9217,0753.4325.67%
3 Months18.2018.4513.0216.0022,119-1.41-7.75%
6 Months14.2134.0011.0015.56142,6792.5818.16%
1 Year15.4034.0011.0016.54229,1301.399.03%
3 Years412.65416.858.71542.32274,608-395.86-95.93%
5 Years250.25462.008.71550.17262,885-233.46-93.29%

Helius Medical Technolog... Description

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.


Your Recent History
NASDAQ
HSDT
Helius Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.